Medicine and Dentistry
Neoplasm
100%
Uterine Myomectomy
82%
Uterine Fibroid
70%
Ovarian Cancer
70%
Uterus Sarcoma
65%
Krukenberg Tumor
65%
Laparotomy
60%
Endometrium Carcinoma
49%
Systematic Review
49%
Gynecological Oncology
49%
Papanicolaou Stain
39%
Combination Therapy
35%
Wart Virus
32%
Recurrent Disease
31%
Malignant Neoplasm
31%
Methylation
30%
Disease
29%
Overall Survival
28%
Gynecology
27%
Cisplatin
26%
Hernia
26%
Biological Marker
25%
Endometriosis
24%
Sarcoma
24%
Endometrial Cancer
23%
Hernioplasty
23%
In Vitro
22%
Bleeding
22%
Bevacizumab
22%
Endometrial Stromal Sarcoma
21%
Menorrhagia
21%
Cytoreductive Surgery
21%
Case-Control Study
20%
Immunocompetent Cell
20%
Laparoscopic Surgery
20%
Squamous Cell Carcinoma
19%
Pelvis
19%
Inguinal Hernia
19%
Angioleiomyoma
19%
Uterine Cancer
19%
Radiation Therapy
19%
Leiomyosarcoma
19%
Laparoscopic Cholecystectomy
19%
Triage
19%
Cell Differentiation
18%
Tumor Microenvironment
18%
Protein Expression
18%
Adenomyosis
18%
Metastatic Carcinoma
18%
Paclitaxel
17%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
37%
Cytokine
32%
Stem Cell
32%
SOX2
29%
Cellular Differentiation
27%
Cancer Stem Cell
24%
Trisomy
23%
Epigenetics
21%
Epidermal Growth Factor Receptor
21%
Epigenomics
20%
Array Comparative Genomic Hybridization
20%
Karyotype
19%
Sialylation
19%
KCNK9
16%
Exome Sequencing
16%
BRCA1
16%
Gene Mutation
16%
Cell Plasticity
16%
Endometrium
16%
Potassium Channel
16%
Demethylase
16%
Oxidative Phosphorylation
16%
Sialyltransferase
16%
Regulatory T Cell
16%
Chromosome Marker
16%
MicroRNA
16%
Monosomy
16%
Messenger RNA
16%
Hematopoietic Cell
16%
Genomics
16%
Chromosome 10
16%
Marker Chromosome
16%
Cell Membrane Potential
16%
Anticancer
16%
Periostin
16%
Prevalence
11%
Oligonucleotide
11%
Dendritic Cell
11%
Methylation
10%
Transcriptome
10%
Protein Kinase B
10%
Fluorescence in Situ Hybridization
9%
Genetics
9%
Microarrays
9%
Carcinogenesis
9%
T Cell
8%
Dioxygenase
8%
Growth Factor Receptor Inhibitor
8%
Wellbeing
8%
Cell Dedifferentiation
8%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Carcinoma
32%
Cisplatin
32%
Endometriosis
24%
Ovary Cancer
23%
Chemotherapy
19%
Menorrhagia
18%
Disease
18%
Adenomyosis
18%
Drug Development
16%
Female Genital Tract Cancer
16%
Comorbidity
16%
Hydronephrosis
16%
Liposarcoma
16%
Hydroureter
16%
Squamous Cell Carcinoma
16%
Combination Therapy
16%
Biological Marker
16%
Potassium Channel
16%
In Vitro Drug Testing
16%
Germ Cell Tumor
16%
Polypropylene
16%
Hernia
16%
Peritoneum Cancer
16%
Etoposide
16%
microRNA
16%
Bleomycin
16%
Stress Incontinence
16%
Bleeding
14%
Neoplasm
13%
Uterine Cervix Cancer
12%
Overall Survival
10%
Observational Study
10%
Diseases
10%
Transcriptome
8%
Malignant Neoplasm
7%
Endometrium Cancer
5%
Dyspareunia
5%
Operative Blood Loss
5%
Postoperative Complication
5%
Prospective Study
5%
Effectiveness Study
5%
Cohort Study
5%
Incontinence
5%
Postoperative Pain
5%
